TNF and rheumatoid arthritis: The current approach to managing RA primarily revolves around the administration of disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate, biologic therapies that encompass tumor necrosis factor (TNF) inhibitors, and the utilization of glucocorticoids [3].